Gilead Sciences Inc (GILD)
Total asset turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 28,754,000 | 27,116,000 | 27,281,000 | 27,305,000 | 24,689,000 |
| Total assets | US$ in thousands | 58,995,000 | 62,125,000 | 63,171,000 | 67,952,000 | 68,407,000 |
| Total asset turnover | 0.49 | 0.44 | 0.43 | 0.40 | 0.36 |
December 31, 2024 calculation
Total asset turnover = Revenue ÷ Total assets
= $28,754,000K ÷ $58,995,000K
= 0.49
The total asset turnover ratio for Gilead Sciences Inc has shown a positive trend over the past five years. From 0.36 in December 31, 2020, the ratio increased to 0.49 by December 31, 2024. This indicates that Gilead Sciences Inc is generating more revenue relative to its total assets, reflecting improved efficiency in asset utilization. The company has been able to effectively deploy its assets to generate sales, which is a positive sign for investors as it suggests stronger operational performance and potentially better returns. Overall, the increasing trend in total asset turnover ratio for Gilead Sciences Inc demonstrates management's ability to make optimal use of the company's assets to drive revenue growth.
Peer comparison
Dec 31, 2024